Singular Genomics Systems, Inc. (OMIC) Social Stream
Singular Genomics Systems Inc (OMIC) Price Targets From Analysts
Use the tables below to see what analysts covering Singular Genomics Systems Inc think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
OMIC's average price target has moved down $12 over the prior 35 weeks.
OMIC reports an average of 98.98% for its upside potential over the past 35 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
OMIC Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
OMIC's average broker recommendation rating improved by 1.2 over the prior 151 days.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- Singular Genomics Systems Inc's upside potential (average analyst target price relative to current price) is higher than 183.63% of all US stocks.
- In the context of all US stocks, Singular Genomics Systems Inc's number of analysts covering the stock is higher than 22.28% of them.
- To contextualize these metrics, consider that out of Measuring and Control Equipment stocks, Singular Genomics Systems Inc's average analyst price target is higher than 32.47% of them.
- In the context of Healthcare stocks, Singular Genomics Systems Inc's variance in analysts' estimates is lower than 50.52% of them.
In the Measuring and Control Equipment industry, NAUT, ISO, and HLTH are the three stocks most similar to Singular Genomics Systems Inc regarding the price target and analyst recommendation information presented here.
Is OMIC a Buy, Hold or Sell? See the POWR Ratings now!